Role of pharmacogenomics in individualising treatment with SSRIs (Q35078269)

6 August 2017

1 reference

title

Role of pharmacogenomics in individualising treatment with SSRIs (English)

1 reference

6 August 2017

1 reference

Dalu Mancama

1

1 reference

PubMed ID

12617694

6 August 2017

Robert W Kerwin

series ordinal

2

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

17

1 reference

6 August 2017

3

1 reference

6 August 2017

143-151

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200317030-00001

6 August 2017

0 references

cites work

Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: infrequent medical adverse effects

1 reference

12 December 2020

Pharmacogenetics and the serotonin system: initial studies and future directions.

1 reference

12 December 2020

Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.

1 reference

12 December 2020

Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro.

1 reference

12 December 2020

Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes

1 reference

12 December 2020

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.

1 reference

12 December 2020

Serotonin transporter gene polymorphism and antidepressant response

1 reference

12 December 2020

Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans

1 reference

12 December 2020

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

12 December 2020

Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression

1 reference

12 December 2020

5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex

1 reference

12 December 2020

Population studies of polymorphisms of the serotonin transporter protein gene

1 reference

12 December 2020

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

1 reference

12 December 2020

The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin

1 reference

12 December 2020

Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain.

1 reference

12 December 2020

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

12 December 2020

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

1 reference

12 December 2020

Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression

1 reference

12 December 2020

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

12 December 2020

Allelic variation of human serotonin transporter gene expression

1 reference

12 December 2020

The antidepressant efficacy of citalopram.

1 reference

12 December 2020

Response to an open trial of a second SSRI in major depression

1 reference

12 December 2020

Current status of antidepressants: clinical pharmacology and therapy

1 reference

12 December 2020

The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression.

1 reference

12 December 2020

The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials.

1 reference

12 December 2020

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

1 reference

12 December 2020

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

1 reference

12 December 2020

Interpersonal factors in brief treatment of depression: further analyses of the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

1 reference

12 December 2020

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

1 reference

12 December 2020

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine

1 reference

12 December 2020

Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees

1 reference

12 December 2020

Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression.

1 reference

12 December 2020

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

1 reference

12 December 2020

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

12 December 2020

Anticholinergic side-effects of antidepressants: studies of the inhibition of salivation

1 reference

12 December 2020

Noradrenergic function and clinical outcome in antidepressant pharmacotherapy

1 reference

12 December 2020

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

1 reference

12 December 2020

cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.

1 reference

12 December 2020

Pharmacogenetics and adverse drug reactions

1 reference

12 December 2020

Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos.

1 reference

12 December 2020

Adverse effects of tricyclic and non-tricyclic antidepressants.

1 reference

12 December 2020

Fluoxetine drug-drug interactions. II.

1 reference

12 December 2020

The cardiotoxicity of the tricyclics

1 reference

12 December 2020

A comparison of paroxetine and placebo in depressed outpatients.

1 reference

12 December 2020

Predictors of response to amine-specific antidepressants.

1 reference

12 December 2020

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

12 December 2020

Serotonin and the prediction of response time to fluoxetine in patients with mild depression

1 reference

12 December 2020

An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells

1 reference

12 December 2020

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

1 reference

12 December 2020

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

1 reference

12 December 2020

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

12 December 2020

1 reference

12 December 2020

Dopaminergic sensitivity and prediction of antidepressant response.

1 reference

12 December 2020

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

12 December 2020

Noradrenergic dysfunction and antidepressant treatment response

1 reference

12 December 2020

Drug metabolism and atypical antipsychotics

1 reference

12 December 2020

Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy

1 reference

12 December 2020

Pharmacogenetic prediction of clozapine response

1 reference

12 December 2020

Personality disorder comorbidity with major depression and response to fluoxetine treatment

1 reference

12 December 2020

A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder

1 reference

12 December 2020

Timing of Onset of Antidepressant Response With Fluoxetine Treatment

1 reference

12 December 2020

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

1 reference

12 December 2020

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

1 reference

12 December 2020

The pharmacogenetics of the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Pharmacogenetics of clozapine response

1 reference

12 December 2020

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review

1 reference

12 December 2020

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

1 reference

12 December 2020

A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo

1 reference

12 December 2020

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

12 December 2020

Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques

1 reference

12 December 2020

Novel therapeutic approaches beyond the serotonin receptor.

1 reference

12 December 2020

Initial sequencing and analysis of the human genome

1 reference

12 December 2020

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.

1 reference

12 December 2020

10.2165/00023210-200317030-00001

Identifiers

DOI

1 reference

PubMed ID

12617694

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12617694